In vivo tracking of tumor-specific T cells

被引：53
|
作者：
Yee, C
Riddell, SR
Greenberg, PD
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
[2] Univ Washington, Med Ctr, Seattle, WA 98195 USA
来源：
CURRENT OPINION IN IMMUNOLOGY | 2001年 / 13卷 / 02期
关键词：
D O I：
10.1016/S0952-7915(00)00196-5
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Novel immunologic assays now enable visualization of the antigen-specific response to an extent not previously possible. Assessment of not only the numeric frequency but also the functional properties of individual tumor-specific T cells in the endogenous and manipulated immune response has provided insights that will facilitate the development of immunotherapeutic strategies.
引用
收藏
页码：141 / 146
页数：6
相关论文
共 50 条
  • [21] Molecularly near-infrared fluorescent theranostics for in vivo tracking tumor-specific chemotherapy
    Yan, Chenxu
    Shi, Limin
    Guo, Zhiqian
    Zhu, Weihong
    CHINESE CHEMICAL LETTERS, 2019, 30 (10) : 1849 - 1855
  • [22] Molecularly near-infrared fluorescent theranostics for in vivo tracking tumor-specific chemotherapy
    Chenxu Yan
    Limin Shi
    Zhiqian Guo
    Weihong Zhu
    ChineseChemicalLetters, 2019, 30 (10) : 1849 - 1855
  • [23] Tumor-specific T cells signal tumor destruction via the lymphotoxin β receptor
    Winter, Hauke
    van den Engel, Natasja K.
    Poehlein, Christian H.
    Hatz, Rudolf A.
    Fox, Bernard A.
    Hu, Hong-Ming
    JOURNAL OF TRANSLATIONAL MEDICINE, 2007, 5 (1)
  • [24] Differential Suppression of Tumor-Specific CD8+ T Cells by Regulatory T Cells
    James, Edward
    Yeh, Alex
    King, Cathy
    Korangy, Firouzeh
    Bailey, Ian
    Boulanger, Denise S.
    Van den Eynde, Benoit J.
    Murray, Nicholas
    Elliott, Tim J.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (09): : 5048 - 5055
  • [25] In vivo clonal expansion of tumor-specific cytotoxic T cells derived from peripheral blood of a melanoma patient
    Sun, Y
    Möller, P
    Berking, C
    Schlüpen, EM
    Volkenandt, M
    Schadendorf, D
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 722 - 722
  • [26] Vaccination with activated B cells pulsed with tumor-lysates can induce tumor-specific CD4+ T cells in vivo
    Ito, O
    Harada, M
    Takenoyama, M
    Tamada, K
    Li, TL
    Abe, K
    Fujie, H
    Nomoto, K
    IMMUNOBIOLOGY, 1998, 199 (01) : 133 - 147
  • [27] Engineered tumor-specific T cells using immunostimulatory photothermal nanoparticles
    Sweeney, Elizabeth E.
    Sekhri, Palak
    Telaraja, Deepti
    Chen, Jie
    Chin, Samantha J.
    Chiappinelli, Katherine B.
    Sanchez, Carlos E.
    Bollard, Catherine M.
    Cruz, C. Russell Y.
    Fernandes, Rohan
    CYTOTHERAPY, 2023, 25 (07) : 718 - 727
  • [28] A novel strategy for efficient cloning of human tumor-specific T cells
    Neelapu, Sattva S.
    Lee, S-T
    Wang, Y-H
    Sukhumalchandra, P.
    Molldrem, J.
    Wieder, E.
    Radvanyi, L.
    Hwu, P.
    Liu, Y-J
    Kwak, L.
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S267 - S267
  • [29] Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells
    Schluck, Marjolein
    Hammink, Roel
    Figdor, Carl G.
    Verdoes, Martijn
    Weiden, Jorieke
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [30] FAS expression limits the effector function of tumor-specific T cells
    Saff, R
    Spanjaard, E
    Hohlbaum, A
    Marshak-Rothstein, A
    JOURNAL OF IMMUNOTHERAPY, 2003, 26 (06): : S23 - S23
12345